,71 In hepatocellular carcinoma, studies have linked CNV changes in genes such as KIAA1429 (also known as vir-like m6A methyltransferase-associated protein (VIRMA)) and METTL16 to hepatocellular carcinoma development, progression, and clinical prognosis. This evidence concerns the gene METTL16 and hepatocellular carcinoma.